Activation of androgen receptor function by a novel nuclear protein kinase

Molecular Biology of the Cell

Volumn 9, Issue 9, 1998, Pages 2527-2543

  Moilanen, Anu Maarit ^a   Karvonen, Ulla ^a   Poukka, Hetti ^a   Jänne, Olli A ^a   Palvimo, Jorma J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; GENE PRODUCT; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; RECEPTOR PROTEIN; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LIGAND BINDING; MAMMAL CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALIA; MAMMALIA;

EID: 0031717887     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.9.2527     Document Type: Article

References (91)

1. Adeyemo, O., Kallio, P.J., Palvimo, J.J., Kontula, K., and Jänne, O.A. (1993). A single-base substitution in exon 6 of the androgen receptor gene causing complete androgen insensitivity: the mutated receptor fails to transactivate but binds to DNA in vitro. Hum. Mol. Genet. 2, 1809-1812.
2. Allgood, V.E., Oakley, R.H., and Cidlowski, J.A. (1993). Modulation by vitamin B6 of glucocorticoid receptor-mediated gene expression requires transcription factors in addition to the glucocorticoid receptor. J. Biol. Chem. 268, 20870-20876.
3. Altschul, S.F., Gish, W., Miller, W., Myers, E.W., and Lipman, D.J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
4. Anzick, S.L., Kononen, J., Walker, R.L., Azorsa, D.O., Tanner, M.M., Guan, X.-Y., Sauter, G., Kallioniemi, O.-P., Trent, J.M., and Meltzer, P.S. (1997). AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277, 965-968.
5. Arnold, S.F., Melamed, M., Vorojeikina, D.P., Notides, A.C., and Sasson, S. (1997). Estradiol-binding mechanism and binding capacity of the human receptor is regulated by tyrosine phosphorylation. Mol. Endocrinol. 11, 48-53.
6. Auffray, C., and Rougeon, F. (1980). Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107, 303-314.
7. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (1997). Current Protocols in Molecular Biology, New York: John Wiley & Sons.
8. Bai, W., Rowan, B.G., Allgood, V.E., O'Malley, B.W., and Weigel, N.L. (1997). Differential phosphorylation of chicken progesterone receptor in hormone-dependent and ligand-independent activation. J. Biol. Chem. 272, 10457-10463.
9. Barratt, M.J., Hazzalin, C.A., Cano, E., and Mahadevan, L.C. (1994). Mitogen-stimulated phosphorylation of histone H3 is targeted to a small hyperacetylation-sensitive fraction. Proc. Natl. Acad. Sci. USA 91, 4781-4785.
10. Bartel, P.L., Chien, C.T., Sternglanz, R., and Fields, S. (1993). Using the two-hybrid system to detect protein-protein interactions. In: Cellular Interactions in Development: A Practical Approach, ed. D.A. Hartley, Oxford, UK: IRL, 153-179.
11. Begley, D.A., Berkenpas, M.B., Sampson, K.E., and Abraham, I. (1997). Identification and sequence of human PKY, a putative kinase with increased expression in multidrug-resistant cells, with homology to yeast protein kinase Yak1. Gene 200, 35-43.
12. Beato, M., Herrlich, P., and Schütz, G. (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83, 851-857.
13. Beato, M., and Sanchez-Pacheco, A. (1996). Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17, 587-609.
14. Beck, C.A., Weigel, N.L., and Edwards, D.P. (1992). Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol. Endocrinol. 6, 607-620.
15. Blanco, J.C.G., Wang, I.-M., Tsai, S.Y., Tsai, M.-J., O'Malley, B.W., Jurutka, P.W., Haussler, M.R., and Ozato, K. (1995). Transcription factor TFIIB and vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl. Acad. Sci. USA 92, 1535-1539.
16. Blok, L.J., de Ruiter, P.E., and Brinkmann, A.O. (1998). Foskolin-induced dephosphorylation of the androgen receptor impairs ligand binding. Biochemistry 37, 3850-3857.
17. Bohen, S.P., and Yamamoto, K.R. (1993). Modulation of steroid receptor signal transduction by heat shock protein. In: The Biology of Heat Shock Proteins and Molecular Chaperones, ed. R. Morimoto, A. Tissieres, and C. Georgopoulos, Cold Spring Harbor, NY: Cold Spring Harbor Press, 313-334.
18. Bunone, G., Briand, P.-A., Miksicek, R.J., and Picard, D. (1996). Activation of the unliganded estrogen receptor involves the MAP kinase pathway and direct phosphorylation. EMBO J. 15, 2174-2183.
19. Cavaillés V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner, P.J., and Parker, M.G. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751.
20. Chakravarti, D., LaMorte, V.J., Nelson, M.C., Nakajima, T., Juguilon, H., Montminy, M., and Evans, R.M. (1996). Role of CBP/p300 in nuclear receptor signalling. Nature 383, 99-103.
21. Cho, H., and Katzenellenbogen, B.S. (1993). Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7, 441-452.
22. Culig, Z., Hobish, A., Cronauer, M., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., and Klocker, H. (1994). Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. Cancer Res. 54, 5474-5478.
23. Denner, L.A., Weigel, N.L., Maxwell, B.L., Schrader, W.T., and O'Malley, B.W. (1990). Regulation of progesterone receptor-mediated transcription by phosphorylation. Science 250, 1740-1743.
24. Eastman, A. (1987). An improvement to the novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5, 73.
25. Fang, Y., Fliss, A.E., Robins, D.M., and Caplan, A.J. (1996). Hsp90 regulates androgen receptor hormone binding affinity in vivo. J. Biol. Chem. 271, 28697-28702.
26. Fliss, A.E., Fang, Y., Boschelli, F., and Caplan, A.J. (1997). Differential in vivo regulation of steroid hormone receptor by Cdc37p. Mol. Biol. Cell 8, 2501-2509.
27. Garrett, S., and Broach, J.R. (1989). Loss of Ras activity in Saccharomyces cerevisiae is suppressed by disruptions of a new kinase gene, YAK1, whose product may act downstream of the cAMP-dependent protein kinase. Genes Dev. 3, 1336-1348.
28. Garrett, S., Menold, M.M., and Broach, J.R. (1991). The Saccharomyces cerevisiae YAK1 gene encodes a protein kinase that is induced by arrest early in the cell cycle. Mol. Cell. Biol. 11, 4045-4052.
29. Gu, W., and Roeder, R.G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
30. Hadzig, E., Desai-Yajnik, V., Helmer, E., Guo, S., Wu, S., Koudinova, N., Casanova, J., Raaka, B.M., and Samuels, H.H. (1995). A 10-amino acid sequence in the N-terminal A/B domain of thyroid hormone receptor a is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol. Cell. Biol. 15, 4507-4517.
31. Hanks, S.K., and Hunter, T. (1995). The eucaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576-596.
32. Hanks, S.K., and Quinn, A.M (1991). The protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. Methods Enzymol. 200, 38-62.
33. Hanstein, B., Eckner, R., DiRenzo, J., Halachmi, S., Liu, H., Searcy, B., Kurokawa, R., and Brown, M. (1996). p300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. USA 93, 11540-11545.
34. Hill, C., and Treisman, R. (1995). Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80, 199-211.
35. Hollenberg, S.M., Sternglanz, R., Cheng, P.F., and Weintraub, H. (1995). Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system. Mol. Cell. Biol. 15, 3813-3822.
36. Hong, H., Kohli, K., Trivedi, A., Johnson, D.L., and Stallcup, M.R. (1996). GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc. Natl. Acad. Sci. USA 93, 4948-4952.
37. Horwitz, K.B., Jackson, T.A., Bain, D.L., Richard, J.K., Takimoto, G.S., and Tung, L. (1996). Nuclear receptor coactivators and corepressors. Mol. Endocrinol. 10, 1167-1177.
38. Hunter, T., and Karin, M. (1992). Regulation of transcription by phosphorylation. Cell 70, 375-385.
39. Ikonen, T., Palvimo, J.J., and Jänne, O.A. (1997). Interaction between amino- and carboxyl-terminal regions of rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J. Biol. Chem. 272, 29821-29828.
40. Ikonen, T., Palvimo, J.J., Kallio, P.J., Reinikainen, P., and Jänne, O.A. (1994). Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135, 1359-1366.
41. Ing, N.H., Beekman, J.M., Tsai, S.Y., Tsai, M.-J., and O'Malley, B.W. (1992). Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267, 17617-17623.
42. II30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79, 107-117.
43. Jelinek, T., and Weber, M.J. (1993). Optimization of the resolution of phosphoamino acids by one-dimensional thin-layer electrophoresis. Biotechniques 15, 629-630.
44. Johnson, L.N., Noble, M.E.M., and Owen, D.J. (1996). Active and inactive protein kinases: structural basis for regulation. Cell 85, 149-158.
45. Kallio, P.J., Poukka, H., Moilanen, A., Jänne, O.A., and Palvimo, J.J. (1995). Androgen receptor mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol. Endocrinol. 9, 1017-1028.
46. Kamei, Y., et al. (1996). A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
47. Karvonen, U., Kallio, P.J., Jänne, O.A., and Palvimo, J.J. (1997). Interaction of androgen receptors with androgen response elements in intact cells: roles of amino- and carboxyl-terminal regions and the ligand. J. Biol. Chem. 272, 15973-15979.
48. Kato, S., et al. (1995). Activation of estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270, 1491-1494.
49. Kentrup, H., Becker, W., Heukelbach, J., Wilmes, A., Schürmann, A., Huppertz, C., Kainulainen, H., and Joost, H.-G. (1996). Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J. Biol. Chem. 271, 3488-3495.
50. Krstic, M.D., Rogatsky, I., Yamamoto, K.R., and Garabedian M.J. (1997). Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17, 3947-3954.
51. Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 22, 680-685.
52. Le Douarin, B., Zechel, C., Garnier, J.-M., Lutz, Y., Tora, L., Pierrat, P., Heery, D., Gronemeyer, H., Chambon, P., and Losson, R. (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14, 2020-2033.
53. Lee, J.W., Ryan, F., Swaffield, S.A., Johnston, S.A., and Moore, D.D. (1995). Interaction of thyroid hormone receptor with a conserved transcriptional mediator. Nature 374, 91-94.
54. Lichtarge, O., Yamamoto, K.R., and Cohen, F.E. (1997). Identification of functional surfaces of the zinc binding domains of intracellular receptors. J. Mol. Biol. 274, 325-337.
55. McEwan, I.J., and Gustafsson, J.-Å. (1997). Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. Proc. Natl. Acad. Sci. USA 94, 8485-8490.
56. II135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells. Genes Dev. 11, 1381-1395.
57. Moilanen, A.-M., Poukka, H., Karvonen, U., Häkli, M., Jänne, O.A., and Palvimo, J.J. (1998). Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol. Cell. Biol. (in press).
58. Moilanen, A.-M., Rouleau, N., Ikonen, T., Palvimo, J.J., and Jänne, O.A. (1997). The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Lett. 412, 355-358.
59. Montminy, M. (1997). Something new to hang your HAT on. Nature 387, 654-655.
60. Moyer, M.L., Borror, K.C., Bona, B.J., DeFranco, D.B., and Nordeen, S.K. (1993). Modulation of cell signalling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation. J. Biol. Chem. 268, 22933-22940.
61. Nazareth, V.L., and Weigel, N.L. (1996). Activation of the human androgen receptor through a protein kinase A signalling pathway. J. Biol. Chem. 271, 19900-19907.
62. Oñate, S.A., Tsai, S.Y., Tsai, M.-J., and O'Malley, B.W. (1995). Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
63. Palvimo, J.J., Kallio, P.J., Ikonen, T., Mehto, M., and Jänne, O.A. (1993). Dominant negative regulation of trans-activation by the rat androgen receptor: roles of the N-terminal domain and heterodimer formation. Mol. Endocrinol. 7, 1399-1028.
64. Palvimo, J., and Mäenpää, P.H. (1988). Binding of high-mobility-group proteins HMG 14 and HMG 17 to DNA and histone H1 as influenced by phosphorylation. Biochim. Biophys. Acta 952, 172-180.
65. Palvimo, J.J., Partanen, M., and Jänne, O.A. (1996). Characterization of a cell specific modulatory element in the murine ornithine decarboxylase promoter. Biochem. J. 316, 993-998.
66. Palvimo, J.J., Reinikainen, P., Ikonen, T., Kallio, P.J., Moilanen, A., and Jänne, O.A. (1996). Mutual transcriptional interference between RelA and androgen receptor. J. Biol. Chem. 271, 24151-24156.
67. Pazin, M.J., and Kadonaga, J.T. (1997). What's up and down with histone deacetylation and transcription. Cell 89, 325-328.
68. Perlmann, T., and Evans, R.M. (1997). Nuclear receptors in Sicily: all in the famiglia. Cell 90, 391-397.
69. Power, R.F., Mani, S.K., Codina, J., Conneely, O.M., and O'Malley, B.W. (1991). Dopaminergic and ligand-independent activation of steroid hormone receptors. Science 254, 1636-1639.
70. Quigley, C.A., DeBellis, A., Marschke, K.B., El-Awady, M.K., Wilson, E.M., and French, F.S. (1995). Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr. Rev. 16, 271-321.
71. Rogatsky, I., Logan, S.K., and Garabedian M.J. (1998). Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 95, 2050-2055.
72. Rosenthal, N. (1987). Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 152, 704-720.
73. Schena, M., Freedman, L.P., and Yamamoto, K.R. (1989). Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev. 3, 1590-1601.
74. Schulman, I.G., Chakravarti, D., Juguilon, H., Romo, A., and Evans, R.M. (1995). Interactions between the retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation. Proc. Natl. Acad. Sci. USA 92, 8288-8292.
75. II110 subunit of the TFIID complex. J. Biol. Chem. 270, 21331-21338.
76. Shindoh, N., Kudoh, J., Hideto, M., Yamaki, A., Minoshima, M., Shimizu, Y., and Shimizu, N. (1996). Cloning of a human homolog of the Drosophila Minibrain/rat Dyrk gene from "the Down syndrome critical region" of chromosome 21. Biochem. Biophys. Res. Commun. 225, 92-99.
77. Smith, D.J., et al. (1997). Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat. Genet. 16, 28-36.
78. Somers, J.P., and DeFranco, D.B. (1992). Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor mediated enhancement. Mol. Endocrinol. 6, 26-34.
79. Song, W.-J., Chung, S.-H., and Kurnit, D.M. (1997). The murine Dyrk protein maps to chromosome 16, localizes to the nucleus, and can form multimers. Biochem. Biophys. Res. Commun. 231, 640-644.
80. Starr, D.B., Matsui, W., Thomas, J.R., and Yamamoto, K.R. (1996). Intracellular receptors use a common mechanism to interpret signaling information at response elements. Genes Dev. 10, 1271-1283.
81. Takeshita, A., Cardona, G.R., Koibuchi, N., Suen, C.S., and Chin, W.W. (1997). TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272, 27629-27634.
82. Tejedor, F., Zhu, X.R., Kaltenbach, E., Ackerman, A., Bauman, A., Canal, I., Heisenberg, M., Fischbach, K.F., and Pongs, O. (1995). Minibrain: a new protein kinase family involved in postembryogenetic neurogenesis in Drosophila. Neuron 14, 287-301.
83. Tjian, R., and Maniatis, T. (1994). Transcriptional activation: a complex puzzle with few easy pieces. Cell 77, 5-8.
84. Voegel, J.J., Hiene, M.J.S., Zechel, C., Chambon, P., and Gronemeyer, H. (1996). TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15, 3667-3675.
85. vom Baur, E., Zechel, C., Heery, D., Heine, M.J.S., Garnier, J.M., Vivat, V., Le Douarin, B., Gronemeyer, H., Chambon, P., and Losson, R. (1996). Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124.
86. Weigel, N.L. (1996). Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 319, 657-667.
87. White R., Sjöberg, M., Kalkhoven, E., and Parker, M.G. (1997). Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J. 16, 1427-1435.
88. Wilson, R. et al. (1994). 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature 368, 32-38.
89. 70, for the androgen receptor in human prostate cells. Proc. Natl. Acad. Sci. USA 93, 5517-5521.
90. Zhou, Z.-X., Lane, V.M., Kemppainen, J.A., and Wilson, E.M. (1995). Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol. Endocrinol. 9, 605-615.
91. Zwijsen, R.M.L., Wientjens, E., Klompmaker, R., van der Sman, J., Bernards, R., and Michalides, R.J.A.M. (1997). CDK-independent activation of estrogen receptor by cyclin D1. Cell 88, 405-415.